N-Acetyl-Cysteine (NAC) in Early Phase Schizophrenia Spectrum Psychosis

Clinical trial NCT01354132 · COMPLETED

Trial details

NCT number: NCT01354132
Sponsor: Beth Israel Deaconess Medical Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Schizophrenic Psychoses

Start date: 2011-05-01
Primary completion: 2014-08-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.